Brief: Active Biotech Q1 Loss per Share at SEK 0.04
04/05/2023 07:34
May 4 (Reuters) - Active Biotech Q1 net income SEK -11.5 million. * Q1 EPS SEK -0.04 * Q1 EBIT SEK -11.8 million
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million